About Imperial College London Diabetes Centre
"Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility specialising in diabetes treatment, research, training and public health awareness. The Centre opened in Abu Dhabi in 2006, in partnership with Imperial College London, as the first healthcare facility established by Mubadala Development Company. Imperial College London Diabetes Centre has developed a tailored, multi-disciplinary, holistic approach to the treatment of diabetes, endocrinology and its related complications so that patients get the full spectrum of care they need, all in one place."
Clinical Trials at Imperial College London Diabetes Centre
During the past decade, Imperial College London Diabetes Centre conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Imperial College London Diabetes Centre"
#1 collaborator was "Georgetown University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Imperial College London Diabetes Centre
According to Clinical.Site data, the most researched conditions in "Imperial College London Diabetes Centre" are
"Diabetes Mellitus, Type 2" (3 trials), "Maturity-onset Diabetes of the Young" (2 trials), "Obesity" (2 trials), "Bariatric Surgery Candidate" (1 trials) and "Cognitive Orientation" (1 trials). Many other conditions were trialed in "Imperial College London Diabetes Centre" in a lesser frequency.
Clinical Trials Intervention Types at Imperial College London Diabetes Centre
Most popular intervention types in "Imperial College London Diabetes Centre" are "Genetic" (4 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Next generation sequencing (NGS)" (3 trials), "No intervention" (2 trials), "Camel milk" (1 trials), "Cow milk" (1 trials) and "Questionnaire" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Imperial College London Diabetes Centre
The vast majority of trials in "Imperial College London Diabetes Centre" are
12 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Imperial College London Diabetes Centre
Currently, there are NaN active trials in "Imperial College London Diabetes Centre".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Imperial College London Diabetes Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Imperial College London Diabetes Centre, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".